Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies.
Rubnitz, Jeffrey E
Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies. [electronic resource] - Leukemia research Apr 2004 - 349-52 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0145-2126
10.1016/j.leukres.2003.08.010 doi
Adolescent
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child, Preschool
Cladribine--administration & dosage
Cytarabine--administration & dosage
Female
Humans
Infant
Leukemia, Myeloid--drug therapy
Male
Recurrence
Treatment Outcome
Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies. [electronic resource] - Leukemia research Apr 2004 - 349-52 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0145-2126
10.1016/j.leukres.2003.08.010 doi
Adolescent
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child, Preschool
Cladribine--administration & dosage
Cytarabine--administration & dosage
Female
Humans
Infant
Leukemia, Myeloid--drug therapy
Male
Recurrence
Treatment Outcome